Internalization and desensitization of adenosine receptors

Palmer TM, Stiles GL (1995) Adenosine receptors. Neuropharmacology 34:683–694

Perez DM, Karnik SS (2005) Multiple signaling states of G-protein-coupled receptors. Pharmacol Rev 57:147–161

Klinger M, Freissmuth M, Nanoff C (2002) Adenosine receptors: G protein-mediated signalling and the role of accessory proteins. Cell Signal 14:99–108

Palmer TM, Stiles GL (1997) Identification of an A2A adenosine receptor domain specifically responsible for mediating short-term desensitization. Biochemistry 36:832–838

Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527–552

Yaar R, Jones MR, Chen JF, Ravid K (2005) Animal models for the study of adenosine receptor function. J Cell Physiol 202:9–20

Jacobson KA, Gao ZG (2006) Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 5:247–264

Beukers MW, Meurs I, Ijzerman AP (2006) Structure-affinity relationships of adenosine A2B receptor ligands. Med Res Rev 26:667–698

Müller CE (2000) Adenosine receptor ligands-recent developments part I. Agonists. Curr Med Chem 7:1269–1288

Klotz KN (2000) Adenosine receptors and their ligands. Naunyn Schmiedebergs Arch Pharmacol 362:382–391

Franco R, Ciruela F, Casado V, Cortes A, Canela EI, Mallol J, Agnati LF, Ferre S, Fuxe K, Lluis C (2005) Partners for A1Rs. J Mol Neurosci 26:221–232

Schwarzschild MA, Agnati L, Fuxe K, Chen JF, Morelli M (2006) Targeting adenosine A2A receptors in Parkinson’s disease. Trends Neurosci 29:647–654

Minghetti L, Greco A, Potenza RL, Pezzola A, Blum D, Bantubungi K, Popoli P (2007) Effects of the adenosine A2A receptor antagonist SCH 58621 on cyclooxygenase-2 expression, glial activation, and brain-derived neurotrophic factor availability in a rat model of striatal neurodegeneration. J Neuropathol Exp Neurol 66:363–371

Dall’Igna OP, Fett P, Gomes MW, Souza DO, Cunha RA, Lara DR (2007) Caffeine and adenosine A2A receptor antagonists prevent beta-amyloid (25–35)-induced cognitive deficits in mice. Exp Neurol 203:241–245

Zhao Z, Yaar R, Ladd D, Cataldo LM, Ravid K (2002) Overexpression of A3 adenosine receptors in smooth, cardiac, and skeletal muscle is lethal to embryos. Microvasc Res 63:61–69

Young HW, Molina JG, Dimina D, Zhong H, Jacobson M, Chan LN, Chan TS, Lee JJ, Blackburn MR (2004) A3 adenosine receptor signaling contributes to airway inflammation and mucus production in adenosine deaminase-deficient mice. J Immunol 173:1380–1389

Gessi S, Cattabriga E, Avitabile A, Gafa’ R, Lanza G, Cavazzini L, Bianchi N, Gambari R, Feo C, Liboni A, Gullini S, Leung E, Mac-Lennan S, Borea PA (2004) Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells. Clin Cancer Res 10:5895–5901

Milligan G, Kostenis E (2006) Heterotrimeric G-proteins: a short history. Br J Pharmacol 147(Suppl 1):S46–S55

Pierce KL, Premont RT, Lefkowitz RJ (2002) Seven-transmembrane receptors. Nat Rev Mol Cell Biol 3:639–650

Moro S, Gao ZG, Jacobson KA, Spalluto G (2006) Progress in the pursuit of therapeutic adenosine receptor antagonists. Med Res Rev 26:131–159

Yabuuchi K, Kuroiwa M, Shuto T, Sotogaku N, Snyder GL, Higashi H, Tanaka M, Greengard P, Nishi A (2006) Role of adenosine A1 receptors in the modulation of dopamine D1 and adenosine A2A receptor signaling in the neostriatum. Neuroscience 141:19–25

Cordeaux Y, Briddon SJ, Megson AE, McDonnell J, Dickenson JM, Hill SJ (2000) Influence of receptor number on functional responses elicited by agonists acting at the human adenosine A1 receptor: evidence for signaling pathway-dependent changes in agonist potency and relative intrinsic activity. Mol Pharmacol 58:1075–1084

Cordeaux Y, Ijzerman AP, Hill SJ (2004) Coupling of the human A1 adenosine receptor to different heterotrimeric G proteins: evidence for agonist-specific G protein activation. Br J Pharmacol 143:705–714

Fredholm BB, Arslan G, Halldner L, Kull B, Schulte G, Wasserman W (2000) Structure and function of adenosine receptors and their genes. Naunyn Schmiedebergs Arch Pharmacol 362:364–374

Ferguson SSG (2001) Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 53:1–24

Chini B, Parenti M (2004) G-protein coupled receptors in lipid rafts and caveolae: how, when and why do they go there? J Mol Endocrinol 32:325–338

Penn RB, Pascual RM, Kim YM, Mundell SJ, Krymskaya VP, Panettieri RA Jr, Benovic JL (2001) Arrestin specificity for G protein-coupled receptors in human airway smooth muscle. J Biol Chem 276:32648–32656

Maudsley S, Martin B, Luttrell LM (2005) The origins of diversity and specificity in G protein-coupled receptor signaling. J Pharmacol Exp Ther 314:485–494

Moore MS, Mahaffey DT, Brodsky FM, Anderson RG (1987) Assembly of clathrin-coated pits onto purified plasma membranes. Science 236:558–563

Sorkin A (2004) Cargo recognition during clathrin-mediated endocytosis: a team effort. Curr Opin Cell Biol 16:392–399

Reiter E, Lefkowitz RJ (2006) GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling. Trends Endocrinol Metab 17:159–165

Burgueno J, Canela EI, Mallol J, Lluis C, Franco R, Ciruela F (2004) Mutual regulation between metabotropic glutamate type 1α receptor and caveolin proteins: from traffick to constitutive activity. Exp Cell Res 300:23–34

Reiter E, Lefkowitz RJ (2006) GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling. Trends Endocrinol Metab 17:159–165

Lefkowitz RJ, Rajagopal K, Whalen EJ (2006) New roles for beta-arrestins in cell signaling: not just for seven-transmembrane receptors. Mol Cell 24:643–652

Ramkumar V, Olah ME, Jacobson KA, Stiles GL (1991) Distinct pathways of desensitization of A1- and A2-adenosine receptors in DDT1 MF-2 cells. Mol Pharmacol 40:639–647

Nie Z, Mei Y, Ramkumar V (1997) Short term desensitization of the A1 adenosine receptors in DDT1MF-2 cells. Mol Pharmacol 52:456–464

Palmer TM, Benovic JL, Stiles GL (1996) Molecular basis for subtype-specific desensitization of inhibitory adenosine receptors. Analysis of a chimeric A1-A3 adenosine receptor. J Biol Chem 271:15272–15278

Klaasse EC, van den Hout G, Roerink SF, de Grip WJ, Ijzerman AP, Beukers MW (2005) Allosteric modulators affect the internalization of human adenosine A1 receptors. Eur J Pharmacol 522:1–8

Vendite D, Sanz JM, Lopez-Alanon DM, Vacas J, Andres A, Ros M (1998) Desensitization of A1R-mediated inhibition of adenylyl cyclase in cerebellar granule cells. Neurochem Res 23:211–218

Wetherington JP, Lambert NA (2002) Differential desensitization of responses mediated by presynaptic and postsynaptic A1 adenosine receptors. J Neurosci 22:1248–1255

Coelho JE, Rebola N, Fragata I, Ribeiro JA, de Mendonca A, Cunha RA (2006) Hypoxia-induced desensitization and internalization of A1Rs in the rat hippocampus. Neuroscience 138:1195–1203

Parsons WJ, Stiles GL (1987) Heterologous desensitization of the inhibitory A1 adenosine receptor-adenylate cyclase system in rat adipocytes. Regulation of both Ns and Ni. J Biol Chem 262:841–847

Longabaugh JP, Didsbury J, Spiegel A, Stiles GL (1989) Modification of the rat adipocyte A1 adenosine receptor-adenylate cyclase system during chronic exposure to an A1 adenosine receptor agonist: alterations in the quantity of $${\text{G}}_{{{\text{s}}\alpha }} $$ and $${\text{G}}_{{{\text{i}}\alpha }} $$ are not associated with changes in their mRNAs. Mol Pharmacol 36:681–688

Ruiz A, Sanz JM, Gonzalez Calero G, Fernandez M, Andres A, Cubero A, Ros M (1996) Desensitization and internalization of A1Rs in rat brain by in vivo treatment with R-PIA: involvement of coated vesicles. Biochim Biophys Acta 1310:168–174

Ruiz MA, Albasanz JL, Leon D, Ros M, Andres A, Martin M (2005) Different modulation of inhibitory and stimulatory pathways mediated by adenosine after chronic in vivo agonist exposure. Brain Res 1031:211–221

Gao Z, Ni Y, Szabo G, Linden J (1999) Palmitoylation of the recombinant human A1 adenosine receptor: enhanced proteolysis of palmitoylation-deficient mutant receptors. Biochem J 342:387–395

Ferguson G, Watterson KR, Palmer TM (2002) Subtype-specific regulation of receptor internalization and recycling by the carboxyl-terminal domains of the human A1 and rat A3 adenosine receptors: consequences for agonist-stimulated translocation of arrestin3. Biochemistry 41:14748–14761

Iacovelli L, Franchetti R, Grisolia D, De Blasi A (1999) Selective regulation of G protein-coupled receptor-mediated signaling by G protein-coupled receptor kinase 2 in FRTL-5 cells: analysis of thyrotropin, α1B-adrenergic, and A1 adenosine receptor-mediated responses. Mol Pharmacol 56:316–324

Saura CA, Mallol J, Canela EI, Lluis C, Franco R (1998) Adenosine deaminase and A1 adenosine receptors internalize together following agonist-induced receptor desensitization. J Biol Chem 273:17610–17617

Escriche M, Burgueño J, Ciruela F, Canela EI, Mallol J, Enrich C, Lluís C, Franco R (2003) Ligand-induced caveolae-mediated internalization of A1 adenosine receptors: morphological evidence of endosomal sorting and receptor recycling. Exp Cell Res 285:72–90

Ginés S, Ciruela F, Burgueño J, Casado V, Canela EI, Mallol J, Lluis C, Franco R (2001) Involvement of caveolin in ligand-induced recruitment and internalization of A1 adenosine receptor and adenosine deaminase in an epithelial cell line. Mol Pharmacol 59:1314–1323

Ciruela F, Saura C, Canela EI, Mallol J, Lluis C, Franco R (1997) Ligand-induced phosphorylation, clustering, and desensitization of A1 adenosine receptors. Mol Pharmacol 52:788–797

Sarrio S, Casado V, Escriche M, Ciruela F, Mallol J, Canela EI, Lluis C, Franco R (2000) The heat shock cognate protein hsc73 assembles with A1 adenosine receptors to form functional modules in the cell membrane. Mol Cell Biol 20:5164–5174

Dunwiddie TV, Diao L, Kim HO, Jiang JL, Jacobson KA (1997) Activation of hippocampal A3Rs produces a desensitization of A1 receptor-mediated responses in rat hippocampus. J Neurosci 17:607–614

Lopes LV, Cunha RA, Ribeiro JA (1999) Cross talk between A1 and A2A adenosine receptors in the hippocampus and cortex of young adult and old rats. J Neurophysiol 82:3196–3203

Ciruela F, Casado V, Rodrigues RJ, Lujan R, Burgueno J, Canals M, Borycz J, Rebola N, Goldberg SR, Mallol J, Cortes A, Canela EI, Lopez-Gimenez JF, Milligan G, Lluis C, Cunha RA, Ferre S, Franco R (2006) Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J Neurosci 26:2080–2087

Selley DE, Cassidy MP, Martin BR, Sim-Selley LJ (2004) Long-term administration of Δ9-tetrahydrocannabinol desensitizes CB1-, adenosine A1-, and GABAB-mediated inhibition of adenylyl cyclase in mouse cerebellum. Mol Pharmacol 66:1275–1284

Ginés S, Hillion J, Torvinen M, Le Crom S, Casado V, Canela EI, Rondin S, Lew JY, Watson S, Zoli M, Agnati LF, Verniera P, Lluis C, Ferre S, Fuxe K, Franco R (2000) Dopamine D1 and A1Rs form functionally interacting heteromeric complexes. Proc Natl Acad Sci U S A 97:8606–8611

Chern Y, Lai HL, Fong JC, Liang Y (1993) Multiple mechanisms for desensitization of A2A adenosine receptor-mediated cAMP elevation in rat pheochromocytoma PC12 cells. Mol Pharmacol 44:950–958

Mundell SJ, Benovic JL, Kelly E (1997) A dominant negative mutant of the G protein-coupled receptor kinase 2 selectively attenuates adenosine A2 receptor desensitization. Mol Pharmacol 51:991–998

Mundell SJ, Kelly E (1998) Evidence for co-expression and desensitization of A2A and A2B adenosine receptors in NG108-15 cells. Biochem Pharmacol 55:595–603

Palmer TM, Gettys TW, Jacobson KA, Stiles GL (1994) Desensitization of the canine A2a adenosine receptor: delineation of multiple processes. Mol Pharmacol 45:1082–1094

Conti A, Lozza G, Monopoli A (1997) Prolonged exposure to 5′-N-ethylcarboxamidoadenosine (NECA) does not affect the adenosine A2A-mediated vasodilation in porcine coronary arteries. Pharmacol Res 35:123–128

Castillo-Melendez M, Krstew E, Lawrence AJ, Jarrott B (1994) Presynaptic adenosine A2A receptors on soma and central terminals of rat vagal afferent neurons. Brain Res 652:137–144

Helfman CC, Zhong H, Barraco RA, Anderson GF (1996) The effects of 5′-N-ethylcarboxamidoadenosine on evoked release of [3H]serotonin in the rat nucleus tractus solitarius. Neurosci Lett 213:61–65

Barraco RA, Helfman CC, Anderson GF (1996) Augmented release of serotonin by adenosine A2a receptor activation and desensitization by CGS 21680 in the rat nucleus tractus solitarius. Brain Res 733:155–161

Rekik M, Mustafa JS (2003) Modulation of A2A adenosine receptors and associated $${\text{G}}_{{\alpha {\text{s}}}} $$ proteins by ZM 241385 treatment of porcine coronary artery. J Cardiovasc Pharmacol 42:736–744

Mundell SJ, Luty JS, Willets J, Benovic JL, Kelly E (1998) Enhanced expression of G protein-coupled receptor kinase 2 selectively increases the sensitivity of A2A adenosine receptors to agonist-induced desensitization. Br J Pharmacol 125:347–356

Khoa ND, Postow M, Danielsson J, Cronstein BN (2006) Tumor necrosis factor-α prevents desensitization of Gαs-coupled receptors by regulating GRK2 association with the plasma membrane. Mol Pharmacol 69:1311–1319

Mundell SJ, Kelly E (1998) The effect of inhibitors of receptor internalization on the desensitization and resensitization of three Gs-coupled receptor responses. Br J Pharmacol 125:1594–1600

Burgueño J, Blake DJ, Benson MA, Tinsley CL, Esapa CT, Canela EI, Penela P, Mallol J, Mayor F Jr, Lluis C, Franco R, Ciruela F (2003) The A2AR interacts with the actin-binding protein alpha-actinin. J Biol Chem 278:37545–37552

Gsandtner I, Freissmuth M (2006) A tail of two signals: the C terminus of the A2A-adenosine receptor recruits alternative signaling pathways. Mol Pharmacol 70:447–449

Gsandtner I, Charalambous C, Stefan E, Ogris E, Freissmuth M, Zezula J (2005) Heterotrimeric G protein-independent signaling of a G protein-coupled receptor. Direct binding of ARNO/cytohesin-2 to the carboxyl terminus of the A2A adenosine receptor is necessary for sustained activation of the ERK/MAP kinase pathway. J Biol Chem 280:31898–31905

Salmi P, Chergui K, Fredholm BB (2005) Adenosine-dopamine interactions revealed in knockout mice. J Mol Neurosci 26:239–244

Canals M, Marcellino D, Fanelli F, Ciruela F, de Benedetti P, Goldberg SR, Neve K, Fuxe K, Agnati LF, Woods AS, Ferre S, Lluis C, Bouvier M, Franco R (2003) Adenosine A2A-dopamine D2 receptor-receptor heteromerization: qualitative and quantitative assessment by fluorescence and bioluminescence energy transfer. J Biol Chem 278:46741–46749

Tang Y, Demarest KT (2005) Distinctive and synergistic signaling of human adenosine A2A and dopamine D2L receptors in CHO cells. J Recept Signal Transduct Res 25:159–179

Vortherms TA, Watts VJ (2004) Sensitization of neuronal A2A adenosine receptors after persistent D2 dopamine receptor activation. J Pharmacol Exp Ther 308:221–227

Hillion J, Canals M, Torvinen M, Casado V, Scott R, Terasmaa A, Hansson A, Watson S, Olah ME, Mallol J, Canela EI, Zoli M, Agnati LF, Ibanez CF, Lluis C, Franco R, Ferre S, Fuxe K (2002) Coaggregation, cointernalization, and codesensitization of A2ARs and dopamine D2 receptors. J Biol Chem 277:18091–18097

Carriba P, Ortiz O, Patkar K, Justinova Z, Stroik J, Themann A, Müller C, Woods AS, Hope BT, Ciruela F, Casadó V, Canela EI, Lluis C, Goldberg SR, Moratalla R, Franco R, Ferré S (2007) Striatal adenosine A2A and cannabinoid CB1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids. Neuropsychopharmacology 32:2249–2259

Peters DM, Gies EK, Gelb CR, Peterfreund RA (1998) Agonist-induced desensitization of A2B adenosine receptors. Biochem Pharmacol 55:873–882

Sitaraman SV, Si-Tahar M, Merlin D, Strohmeier GR, Madara JL (2000) Polarity of A2B adenosine receptor expression determines characteristics of receptor desensitization. Am J Physiol Cell Physiol 287:1230–1236

Trincavelli ML, Marroni M, Tuscano D, Ceruti S, Mazzola A, Mitro N, Abbracchio MP, Martini C (2004) Regulation of A2B adenosine receptor functioning by tumour necrosis factor a in human astroglial cells. J Neurochem 91:1180–1190

Mundell SJ, Olah ME, Panettieri RA, Benovic JL, Penn RB (2001) Regulation of G protein-coupled receptor-adenylyl cyclase responsiveness in human airway smooth muscle by exogenous and autocrine adenosine. Am J Respir Cell Mol Biol 24:155–163

Haynes J, Obiako B, Babal P, Stevens T (1999) 5-(N-ethylcarboxamido)adenosine desensitizes the A2B-adenosine receptor in lung circulation. Am J Physiol 276:H1877–H1883

Matharu AL, Mundell SJ, Benovic JL, Kelly E (2001) Rapid agonist-induced desensitization and internalization of the A2B adenosine receptor is mediated by a serine residue close to the COOH terminus. J Biol Chem 276:30199–30207

Mundell SJ, Matharu AL, Kelly E, Benovic JL (2000) Arrestin isoforms dictate differential kinetics of A2B adenosine receptor trafficking. Biochemistry 39:12828–12836

Lee DK, Lanca AJ, Cheng R, Nguyen T, Ji XD, Gobeil F Jr, Chemtob S, George SR, O’Dowd BF (2004) Agonist-independent nuclear localization of the Apelin, angiotensin AT1, and bradykinin B2 receptors. J Biol Chem 279:7901–7908

Ramkumar V, Stiles GL, Beaven MA, Ali H (1993) The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 268:16887–16890

Trincavelli ML, Tuscano D, Cecchetti P, Falleni A, Benzi L, Klotz KN, Gremigni V, Cattabeni F, Lucacchini A, Martini C (2000) Agonist-induced internalization and recycling of the human A3 adenosine receptors: role in receptor desensitization and resensitization. J Neurochem 75:1493–1501

Palmer TM, Harris CA, Coote J, Stiles GL (1997) Induction of multiple effects on adenylyl cyclase regulation by chronic activation of the human A3 adenosine receptor. Mol Pharmacol 52:632–640

Ferguson G, Watterson KR, Palmer TM (2000) Subtype-specific kinetics of inhibitory adenosine receptor internalization are determined by sensitivity to phosphorylation by G protein-coupled receptor kinases. Mol Pharmacol 57:546–552

Trincavelli ML, Tuscano D, Marroni M, Falleni A, Gremigni V, Ceruti S, Abbracchio MP, Jacobson KA, Cattabeni F, Martini C (2002) A3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization, and down-regulation. Mol Pharmacol 62:1373–1384

Madi L, Bar-Yehuda S, Barer F, Ardon E, Ochaion A, Fishman P (2003) A3 adenosine receptor activation in melanoma cells: association between receptor fate and tumor growth inhibition. J Biol Chem 278:42121–42130

Merighi S, Benini A, Mirandola P, Gessi S, Varani K, Leung E, Maclennan S, Borea PA (2006) Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells. Biochem Pharmacol 72:19–31

Yamano K, Inoue M, Masaki S, Saki M, Ichimura M, Satoh M (2005) Human A3R leads to intracellular Ca2+ mobilization but is insufficient to activate the signaling pathway via phosphoinositide 3-kinase gamma in mice. Biochem Pharmacol 70:1487–1496

Palmer TM, Stiles GL (2000) Identification of threonine residues controlling the agonist-dependent phosphorylation and desensitization of the rat A3 adenosine receptor. Mol Pharmacol 57:539–545

Trincavelli ML, Tuscano D, Marroni M, Klotz KN, Lucacchini A, Martini C (2002) Involvement of mitogen protein kinase cascade in agonist-mediated human A3 adenosine receptor regulation. Biochim Biophys Acta 19:55–62

Santini F, Penn RB, Gagnon AW, Benovic JL, Keen JH (2000) Selective recruitment of arrestin-3 to clathrin-coated pits upon stimulation of G protein-coupled receptors. J Cell Sci 113:2463–2470